{
    "eid": "2-s2.0-85135013381",
    "title": "Pharmacokinetics of isoniazid and rifapentine in young pediatric patients with latent tuberculosis infection",
    "cover-date": "2022-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Antituberculosis drugs",
        "Isoniazid",
        "Latent tuberculosis infection",
        "Pediatrics",
        "Pharmacokinetics",
        "Rifapentine"
    ],
    "authors": [
        "Weeraya Phaisal",
        "Watsamon Jantarabenjakul",
        "Noppadol Wacharachaisurapol",
        "Monta Tawan",
        "Thanyawee Puthanakit",
        "Supeecha Wittayalertpanya",
        "Pajaree Chariyavilaskul"
    ],
    "citedby-count": 1,
    "ref-count": 60,
    "ref-list": [
        "Influences of diet and nutrition on clinical pharmacokinetics",
        "The effect of dietary protein on the clearance of allopurinol and oxypurinol",
        "Pharmacokinetics of rifapentine in children",
        "Update of recommendations for use of once-weekly isoniazid-rifapentine regimen to treat latent Mycobacterium tuberculosis infection",
        "Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients",
        "Population pharmacokinetics of cycloserine and pharmacokinetic/pharmacodynamic target attainment in multidrug-resistant tuberculosis patients dosed with terizidone",
        "Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis",
        "Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis",
        "Safety and adherence for 12 weekly doses of isoniazid and rifapentine for pediatrictuberculosisinfection",
        "Completion rate and safety of tuberculosis infection treatment with shorter regimens",
        "Pharmacokinetics of isoniazid, pyrazinamide, and ethambutol in newly diagnosed pulmonary TB patients in Tanzania",
        "A population pharmacokinetic analysis shows that arylacetamide deacetylase (AADAC) gene polymorphism and HIV infection affect the exposure of rifapentine",
        "Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products",
        "Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review",
        "Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up",
        "A validated high-performance liquid chromatography method for the determination of rifampicin and desacetyl rifampicin in plasma and urine",
        "Rifapentine population pharmacokinetics and dosing recommendations for latent tuberculosis infection",
        "NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis",
        "Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis",
        "Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study",
        "PharmGKB summary: isoniazid pathway, pharmacokinetics",
        "Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs",
        "Impact of food intake on the pharmacokinetics of first-line antituberculosis drugs in Taiwanese tuberculosis patients",
        "Anti-tuberculosis drug induced hepatotoxicity and associated factors among tuberculosis patients at selected hospitals, Ethiopia",
        "Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?",
        "Rifapentine for the treatment of pulmonary tuberculosis",
        "Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine",
        "Tuberculosis infection in children and adolescents: testing and treatment",
        "Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity",
        "Simultaneous determination of rifampicin, isoniazid, pyrazinamide and ethambutol in fixed-dose combination antituberculosis pharmaceutical formulations: a review",
        "Effect of dietary protein on renal tubular clearance of drugs in humans",
        "Adverse events associated with weekly short course isoniazid and rifapentine therapy in pediatric patients with latent tuberculosis: a chart and literature review",
        "Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil",
        "Study of the interaction between rifapentine and isoniazid under acid conditions",
        "Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial",
        "High rate of treatment completion in program settings with 12-dose weekly isoniazid and rifapentine for latent Mycobacterium tuberculosis infection",
        "Defining the optimal dose of rifapentine for pulmonary tuberculosis: exposure\u2013response relations from two phase II clinical trials",
        "Studies on the inactivation of isonicotinyl acid hydrazide in normal subjects and tuberculous patients",
        "Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020",
        "Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: a multicenter randomized controlled trial in Taiwan",
        "Genomewide association study confirming the association of NAT2 with susceptibility to antituberculosis drug-induced liver injury in Thai patients",
        "Drug concentration thresholds predictive of therapy failure and death in children with tuberculosis: bread crumb trails in random forests",
        "Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana",
        "Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid",
        "Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population",
        "NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients",
        "Biostatistics: a foundation for analysis in the health sciences",
        "Clinical pharmacokinetics of isoniazid",
        "Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis",
        "Rifapentine pharmacokinetics and tolerability in children and adults treated once weekly with rifapentine and isoniazid for latent tuberculosis infection",
        "Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients",
        "Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption",
        "High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-a single center study",
        "Assessing food effects on oral drug absorption based on the degree of renal excretion",
        "Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ratchadaphiseksomphot Endowment Fund",
        "RatchadapisekSomphot Fund",
        "Chulalongkorn University",
        "Ministry of Public Health, Thailand",
        "Faculty of Medicine, Chulalongkorn University",
        "Health Systems Research Institute"
    ]
}